2:57 PM
Jul 10, 2018
 |  BC Extra  |  Company News

Management tracks: G1, Collegium, Nimbus

Cancer company G1 Therapeutics Inc. (NASDAQ:GTHX) hired John Demaree as chief commercial officer and Stillman Hanson as general counsel. Demaree was VP of oncology marketing at Astellas Pharma Inc. (Tokyo:4503). Hanson was associate general counsel and VP at Quintiles Transnational Holdings Inc., which is now part of IQVia Holdings Inc. (NYSE:IQV).

Pain company Collegium Pharmaceutical Inc. (NASDAQ:COLL) promoted Scott...

Read the full 274 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >